Trevi Therapeutics, Inc. (TRVI)
14.17
+1.18
(+9.08%)
USD |
NASDAQ |
Dec 10, 16:00
14.30
+0.13
(+0.92%)
After-Hours: 07:55
Trevi Therapeutics Price: 14.17 for Dec. 10, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 97.62 |
| Arbutus Biopharma Corp. | 4.59 |
| NovaBay Pharmaceuticals, Inc. | 2.42 |
| Palatin Technologies, Inc. | 25.62 |
| Theriva Biologics, Inc. | 0.2215 |
Price Related Metrics
| Price to Book Value | 9.574 |
| Earnings Yield | -2.62% |
| Market Cap | 1.817B |